867 related articles for article (PubMed ID: 16436496)
1. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
Rao GK; Kaminski NE
J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
[TBL] [Abstract][Full Text] [Related]
3. Role of cannabinoid receptors in inhibiting macrophage costimulatory activity.
Chuchawankul S; Shima M; Buckley NE; Hartmann CB; McCoy KL
Int Immunopharmacol; 2004 Feb; 4(2):265-78. PubMed ID: 14996418
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells.
Rao GK; Zhang W; Kaminski NE
J Leukoc Biol; 2004 May; 75(5):884-92. PubMed ID: 14966196
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids.
Börner C; Höllt V; Sebald W; Kraus J
J Leukoc Biol; 2007 Jan; 81(1):336-43. PubMed ID: 17041005
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
Showalter VM; Compton DR; Martin BR; Abood ME
J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
[TBL] [Abstract][Full Text] [Related]
7. Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol.
Buchweitz JP; Karmaus PW; Williams KJ; Harkema JR; Kaminski NE
J Leukoc Biol; 2008 Mar; 83(3):785-96. PubMed ID: 18073275
[TBL] [Abstract][Full Text] [Related]
8. Induction of intracellular calcium elevation by Delta9-tetrahydrocannabinol in T cells involves TRPC1 channels.
Rao GK; Kaminski NE
J Leukoc Biol; 2006 Jan; 79(1):202-13. PubMed ID: 16244107
[TBL] [Abstract][Full Text] [Related]
9. Role of cannabinoid receptors in Delta-9-tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila.
Lu T; Newton C; Perkins I; Friedman H; Klein TW
Eur J Pharmacol; 2006 Feb; 532(1-2):170-7. PubMed ID: 16443217
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
Sain NM; Liang A; Kane SA; Urban MO
Neuropharmacology; 2009 Sep; 57(3):235-41. PubMed ID: 19538975
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.
Papahatjis DP; Kourouli T; Abadji V; Goutopoulos A; Makriyannis A
J Med Chem; 1998 Mar; 41(7):1195-200. PubMed ID: 9544219
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
Ligresti A; Moriello AS; Starowicz K; Matias I; Pisanti S; De Petrocellis L; Laezza C; Portella G; Bifulco M; Di Marzo V
J Pharmacol Exp Ther; 2006 Sep; 318(3):1375-87. PubMed ID: 16728591
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors.
Braun A; Engel T; Aguilar-Pimentel JA; Zimmer A; Jakob T; Behrendt H; Mempel M
Immunobiology; 2011 Apr; 216(4):466-76. PubMed ID: 21056512
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors.
Govaerts SJ; Hermans E; Lambert DM
Eur J Pharm Sci; 2004 Nov; 23(3):233-43. PubMed ID: 15489124
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity.
Melvin LS; Milne GM; Johnson MR; Wilken GH; Howlett AC
Drug Des Discov; 1995 Nov; 13(2):155-66. PubMed ID: 8872458
[TBL] [Abstract][Full Text] [Related]
16. Activation of human T cells induces upregulation of cannabinoid receptor type 1 transcription.
Börner C; Höllt V; Kraus J
Neuroimmunomodulation; 2007; 14(6):281-6. PubMed ID: 18287809
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptors in conjunctival epithelium: identification and functional properties.
Iribarne M; Torbidoni V; Julián K; Prestifilippo JP; Sinha D; Rettori V; Berra A; Suburo AM
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4535-44. PubMed ID: 18566465
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids and the skeleton: from marijuana to reversal of bone loss.
Bab I; Zimmer A; Melamed E
Ann Med; 2009; 41(8):560-7. PubMed ID: 19634029
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
Wilkinson JD; Williamson EM
J Dermatol Sci; 2007 Feb; 45(2):87-92. PubMed ID: 17157480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
